Matrix Degradability Contributes to the Development of Salivary Gland Progenitor Cells with Secretory Functions.


Journal

ACS applied materials & interfaces
ISSN: 1944-8252
Titre abrégé: ACS Appl Mater Interfaces
Pays: United States
ID NLM: 101504991

Informations de publication

Date de publication:
12 Jul 2023
Historique:
pmc-release: 12 07 2024
medline: 14 7 2023
pubmed: 27 6 2023
entrez: 26 6 2023
Statut: ppublish

Résumé

Synthetic matrices that are cytocompatible, cell adhesive, and cell responsive are needed for the engineering of implantable, secretory salivary gland constructs to treat radiation induced xerostomia or dry mouth. Here, taking advantage of the bioorthogonality of the Michael-type addition reaction, hydrogels with comparable stiffness but varying degrees of degradability (100% degradable, 100DEG; 50% degradable, 50DEG; and nondegradable, 0DEG) by cell-secreted matrix metalloproteases (MMPs) were synthesized using thiolated HA (HA-SH), maleimide (MI)-conjugated integrin-binding peptide (RGD-MI), and MI-functionalized peptide cross-linkers that are protease degradable (GIW-bisMI) or nondegradable (GIQ-bisMI). Organized multicellular structures developed readily in all hydrogels from dispersed primary human salivary gland stem cells (hS/PCs). As the matrix became progressively degradable, cells proliferated more readily, and the multicellular structures became larger, less spherical, and more lobular. Immunocytochemical analysis showed positive staining for stem/progenitor cell markers CD44 and keratin 5 (K5) in all three types of cultures and positive staining for the acinar marker α-amylase under 50DEG and 100DEG conditions. Quantitatively at the mRNA level, the expression levels of key stem/progenitor markers

Identifiants

pubmed: 37364369
doi: 10.1021/acsami.3c03064
pmc: PMC10529452
mid: NIHMS1916364
doi:

Substances chimiques

Hydrogels 0
Sulfhydryl Compounds 0
maleimide 2519R1UGP8
Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

32148-32161

Subventions

Organisme : NIGMS NIH HHS
ID : P20 GM103446
Pays : United States
Organisme : NIDCD NIH HHS
ID : R01 DC014461
Pays : United States
Organisme : NIDCR NIH HHS
ID : R01 DE029655
Pays : United States
Organisme : NIH HHS
ID : S10 OD016361
Pays : United States

Références

Clin Cancer Res. 2008 Dec 1;14(23):7741-50
pubmed: 19047101
Tissue Eng Part A. 2009 Nov;15(11):3309-20
pubmed: 19382872
Nat Rev Mol Cell Biol. 2007 Mar;8(3):221-33
pubmed: 17318226
Physiology (Bethesda). 2018 Jan 1;33(1):16-25
pubmed: 29212889
Acta Biomater. 2016 Sep 1;41:169-80
pubmed: 27208640
Radiother Oncol. 2009 Sep;92(3):466-71
pubmed: 19625095
Sci Rep. 2022 Sep 02;12(1):15008
pubmed: 36056161
Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S58-63
pubmed: 20171519
Tissue Eng Part A. 2015 Jun;21(11-12):1733-51
pubmed: 25762214
Radiat Oncol. 2019 Jul 29;14(1):131
pubmed: 31358029
Biomater Sci. 2016 Apr;4(4):592-604
pubmed: 26878077
Lancet. 2021 Dec 18;398(10318):2289-2299
pubmed: 34562395
Biomaterials. 2013 Sep;34(28):6797-803
pubmed: 23777918
Science. 2010 Sep 24;329(5999):1645-7
pubmed: 20929848
J Cell Biol. 2011 Mar 21;192(6):907-17
pubmed: 21422226
Semin Oncol. 2019 Jun;46(3):233-245
pubmed: 31378376
Cold Spring Harb Perspect Biol. 2013 Feb 01;5(2):
pubmed: 23378592
Radiother Oncol. 2013 Sep;108(3):458-63
pubmed: 23769181
ACS Biomater Sci Eng. 2021 Dec 13;7(12):5749-5761
pubmed: 34781679
Dev Cell. 2014 Jun 23;29(6):662-73
pubmed: 24960693
Biomaterials. 2013 Jul;34(21):5117-27
pubmed: 23602364
Biosensors (Basel). 2014 Feb 27;4(1):18-27
pubmed: 25587408
CA Cancer J Clin. 2022 Jan;72(1):7-33
pubmed: 35020204
Biochem Biophys Rep. 2017 Sep 12;12:108-113
pubmed: 28955798
PLoS One. 2014 Jun 09;9(6):e99587
pubmed: 24911871
Transl Oncol. 2022 Jul;21:101426
pubmed: 35460943
Cell. 2021 Jul 8;184(14):3702-3716.e30
pubmed: 34133940
ACS Biomater Sci Eng. 2016 Dec 12;2(12):2217-2230
pubmed: 27990487
ACS Biomater Sci Eng. 2019 Sep 9;5(9):4531-4541
pubmed: 33178886
Science. 1989 Feb 17;243(4893):947-50
pubmed: 2465572
Laryngoscope. 2014 Feb;124(2):456-61
pubmed: 23832678
Breast Cancer Res. 2004;6(1):1-11
pubmed: 14680479
Biomaterials. 2010 Oct;31(30):7836-45
pubmed: 20667588
Soft Matter. 2012;8(12):3280-3294
pubmed: 22419946
Curr Biol. 2008 Apr 8;18(7):507-13
pubmed: 18394894
Cell. 2019 Mar 7;176(6):1379-1392.e14
pubmed: 30773315
Nat Rev Mol Cell Biol. 2014 Dec;15(12):786-801
pubmed: 25415508
Mol Ther Methods Clin Dev. 2020 Jul 31;18:839-855
pubmed: 32953934
Dev Dyn. 2017 Feb;246(2):135-147
pubmed: 27884045
Biomaterials. 2016 Sep;101:199-206
pubmed: 27289380
J Dent Res. 2021 Mar;100(3):268-275
pubmed: 33043768
Biomaterials. 2008 Jun;29(17):2637-45
pubmed: 18377982
Adv Biosyst. 2019 Sep;3(9):e1900128
pubmed: 32648654
J Clin Med. 2020 Dec 18;9(12):
pubmed: 33353023
Mol Pathol. 1998 Aug;51(4):175-84
pubmed: 9893742
Genesis. 2018 May;56(5):e23211
pubmed: 29663717
BMC Oral Health. 2021 Oct 27;21(1):552
pubmed: 34706704
Dev Biol. 2006 Oct 15;298(2):540-54
pubmed: 16890932
Stem Cells Transl Med. 2017 Jan;6(1):110-120
pubmed: 28170182
J Biol Chem. 1998 Sep 18;273(38):24360-7
pubmed: 9733724
Biomaterials. 2019 Apr;198:135-145
pubmed: 30174198
Int J Mol Sci. 2020 Dec 20;21(24):
pubmed: 33419373
Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):1187-94
pubmed: 15990024
Histochem Cell Biol. 2000 Dec;114(6):483-8
pubmed: 11201610
Nat Mater. 2013 May;12(5):458-65
pubmed: 23524375
PLoS One. 2011;6(8):e23899
pubmed: 21909376
Radiother Oncol. 2015 Sep;116(3):443-8
pubmed: 26138058
Curr Opin Genet Dev. 2013 Aug;23(4):408-14
pubmed: 23849799
Genomics Proteomics Bioinformatics. 2022 Feb;20(1):101-109
pubmed: 33631432
Bioengineering (Basel). 2022 Jan 15;9(1):
pubmed: 35049747
Front Physiol. 2020 Jun 16;11:661
pubmed: 32612540
Nat Mater. 2017 Dec;16(12):1233-1242
pubmed: 29115291
Stem Cells. 2017 Jan;35(1):97-105
pubmed: 27406006
Stem Cell Reports. 2013 Dec 12;1(6):604-19
pubmed: 24371813
Tissue Eng Part A. 2013 Jul;19(13-14):1610-20
pubmed: 23442148
Acta Biomater. 2017 Mar 1;50:437-449
pubmed: 28039063
Laryngoscope. 1994 Mar;104(3 Pt 1):335-40
pubmed: 8127192
NPJ Regen Med. 2021 Feb 1;6(1):4
pubmed: 33526786
J Cell Biol. 1997 Dec 29;139(7):1861-72
pubmed: 9412478

Auteurs

Apoorva S Metkari (AS)

Department of Materials Science and Engineering, University of Delaware, Newark, Delaware 19716, United States.

Eric W Fowler (EW)

Department of Materials Science and Engineering, University of Delaware, Newark, Delaware 19716, United States.

Robert L Witt (RL)

Helen F. Graham Cancer Center and Research Institute, Newark, Delaware 19713, United States.

Xinqiao Jia (X)

Department of Materials Science and Engineering, University of Delaware, Newark, Delaware 19716, United States.
Department of Biomedical Engineering, University of Delaware, Newark, Delaware 19716, United States.
Department of Biological Sciences, University of Delaware, Newark, Delaware 19716, United States.
Delaware Biotechnology Institute, 590 Avenue 1743, Newark, Delaware 19713, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH